Expand PCVX Menu
PCVX MENU

PCVX Stock Posts


Unusual Option Volume

PCVX Vaxcyte41.35-1.48 (-3.5%)

Vaxcyte trades 2,748 contracts. The highest volume is in the 21-Nov-25 30 puts.
View Details...
Unusual Option Volume

PCVX Vaxcyte29.17-0.88 (-2.9%)

Vaxcyte trades 2,508 contracts. The highest volume is in the 17-Oct-25 35 calls, which is 20.0% above the current price.
View Details...
Unusual Option Volume

PCVX Vaxcyte36.05-33.41 (-48.1%)

Vaxcyte trades 6,196 contracts. The company has the following event: Webcast and Conference Call to Present Topline Results from VAX-24 Infant Phase 2 Study on Mar 31, 2025. News: Vaxcyte Announces Positive Topline Results from VAX-24 Infant Phase 2 Dose-Finding Study
View Details...
PCVX #Vaxcyte stock declines -36.8% in premarket,

Premarket Decliner

PCVX Vaxcyte69.46-1.31-1.9%

Premarket:43.89-25.57 (-36.8%)

Vaxcyte Announces Positive Topline Results from VAX-24 Infant Phase 2 Dose-Finding Study

Globe NewswireMon, 31-Mar 7:00 AM
Upcoming Earnings

PCVX Vaxcyte82.07+0.39 (+0.5%)

Vaxcyte will report earnings after the market closes. View Calendar The market is expecting a ±18.2% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±4.3%. View Expected Move (Conf Call: Feb 25 4:30 PM)
Unusual Option Volume

PCVX Vaxcyte92.50+1.59 (+1.8%)

Vaxcyte trades 3,155 contracts.
View Details...
Load Earlier Posts
Market Data Delayed 15 Minutes